Cancer patients often receive powerful medicines through an intravenous line in their arm. This method requires a nurse to be present and can be uncomfortable. Now, a major analysis of data from 1,243 patients offers good news for those who want to avoid the needle in their vein. The study looked at drugs called PD-1/PD-L1 inhibitors, which help the body fight back against solid tumors like lung or breast cancer. The results show that giving these same drugs under the skin produces the same life-saving results.
When researchers compared the two methods, they found no difference in how long patients lived or how well the drugs stopped the cancer from growing. The rate of tumors shrinking was also the same whether the drug went into the skin or the vein. This means patients can choose a route that feels less invasive without losing out on the treatment's power.
Of course, the body reacts differently to each method. Some patients experienced more joint pain with the skin shots, while others had more reactions at the injection site with the vein method. These side effects were manageable and did not stop the treatment. The study confirms that under-the-skin delivery is a safe and effective option.
This finding is a practical win for patients and doctors. It supports using skin shots as a reliable alternative to traditional vein delivery. Patients can discuss this option with their care team to find the delivery method that fits their daily life best.